Abstract
Background and purpose
Increased high-mobility group box 1 (HMGB1) levels were found in patients after acute ischemic stroke. The aim of this study was to examine whether the circulating HMGB1 levels could predict the 3-month post-stroke depression (PSD).
Methods
The subjects were first-ever ischemic stroke patients who were hospitalized during the period from July 2020 to December 2020. HMGB1 concentrations were measured by enzyme-linked immunosorbent assay after admission. A 24-item Hamilton Depression Rating Scale was performed to evaluate PSD at 3 months after stroke.
Results
The analyses included 324 participants (mean age, 63.7 years; 171 male). Ninety-four patients (29.0%) were diagnosed as having PSD at 3 months. The median serum HMGB1 levels at admission was 7.5 ng/mL (IQR, 4.4–11.3 ng/mL). The PSD distribution across the HMGB1 quartiles ranged between 17.5% (first quartile) and 57.5% (fourth quartile). After covariate adjustments, the fourth quartile of HMGB1 was found to be associated with a higher risk of PSD (as compared with first HMGB1 quartile, odd ratio, 1.26; 95% confidence interval [CI], 1.17–1.35; P < 0.001). The area under the receiver operating characteristic curve of HMGB1 was 0.726 (95% CI 0.660–0.792) for PSD. Similar results were found when HMGB1 was analyzed as continuous variable. Furthermore, the optimal cutoff point of circulating HMGB1 levels was 8.6 ng/mL, with a sensitivity of 69.2% and a specificity of 73.9%.
Conclusions
This study demonstrated that higher HMGB1 levels in the acute phase of ischemic stroke were associated with increased risk of PSD.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available on request from the corresponding author.
References
GBD 2016 (2019) Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):439–58
Giroud M, Jacquin A, Béjot Y (2014) The worldwide landscape of stroke in the 21st century. Lancet 383:195–197
Zhang X, Tang Y, **e Y et al (2017) Total magnetic resonance imaging burden of cerebral small-vessel disease is associated with post-stroke depression in patients with acute lacunar stroke. Eur J Neurol 24:374–380
Hackett M, Pickles K (2014) Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke 9:1017–1025
Hackett M, Yapa C, Parag V, Anderson C (2005) Frequency of depression after stroke: a systematic review of observational studies. Stroke 36:1330–1340
Robinson R, Jorge R (2016) Post-stroke depression: a review. Am J Psychiatry 173:221–231
Cai W, Mueller C, Li Y, Shen W, Stewart R (2019) Post stroke depression and risk of stroke recurrence and mortality: a systematic review and meta-analysis. Ageing Res Rev 50:102–109
Villa R, Ferrari F, Moretti A (2018) Post-stroke depression: mechanisms and pharmacological treatment. Pharmacol Ther 184:131–144
Klune J, Dhupar R, Cardinal J, Billiar T, Tsung A (2008) HMGB1: endogenous danger signaling. Mol Med 14:476–484
Lu B, Wang C, Wang M et al (2014) Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol 10:713–727
Fonken L, Frank M, Kitt M et al (2016) The Alarmin HMGB1 mediates age-induced neuroinflammatory priming. J Neurosci 36:7946–7956
Harris H, Andersson U, Pisetsky D (2012) HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8:195–202
Singh V, Roth S, Veltkamp R, Liesz A (2016) HMGB1 as a key mediator of immune mechanisms in ischemic stroke. Antioxid Redox Signal 24:635–651
Yang Q, Wang J, Li J et al (2010) High-mobility group protein box-1 and its relevance to cerebral ischemia. J Cereb Blood Flow Metab 30:243–254
Zhang J, Takahashi H, Liu K et al (2011) Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 42:1420–1428
Schulze J, Zierath D, Tanzi P et al (2013) Severe stroke induces long-lasting alterations of high-mobility group box 1. Stroke 44:246–248
Lian Y, Gong H, Wu T et al (2017) Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1. Brain Behav Immun 59:322–332
Lei C, Geng J, Zhong L (2020) The association between plasma HMGB1 and sRAGE and clinical outcome in intracerebral hemorrhage. J Neuroimmunol 15(345):577266
Tsukagawa T, Katsumata R, Fujita M et al (2017) Elevated serum high-mobility group box-1 protein level is associated with poor functional outcome in ischemic stroke. J Stroke Cerebrovasc Dis 26:2404–2411
Brott T, Adams HJ, Olinger C et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870
Adams HJ, Bendixen B, Kappelle L, Biller J, Love B, Gordon D (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35–41
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Wang G, Zhou Y, Bu X et al (2019) Antiphospholipid antibodies predict post-stroke depression after acute ischemic stroke. J Affect Disord 257:160–165
Chen Y, Qu J, **ao W et al (2016) Intracranial atherosclerosis and poststroke depression in Chinese patients with ischemic stroke. J Stroke Cerebrovasc Dis 25:998–1004
Wang J, Jiang Y, Zeng D, Zhou W, Hong X (2020) Prognostic value of plasma HMGB1 in ischemic stroke patients with cerebral ischemia-reperfusion injury after intravenous thrombolysis. J Stroke Cerebrovasc Dis 29(9):105055
Wu T, Liu L, Zhang W et al (2015) High-mobility group box-1 was released actively and involved in LPS induced depressive-like behavior. J Psychiatr Res 64:99–106
Ye Y, Zeng Z, ** T, Gu L (2019) The role of high mobility group box 1 in ischemic stroke. Front Cell Neurosci 13:127
Wang C, Jiang J, Zhang X, Song L, Sun K, Xu R (2016) Inhibiting HMGB1 reduces cerebral ischemia reperfusion injury in diabetic mice. Inflammation 39:1862–1870
Bonanno G, Raiteri L, Milanese M et al (2007) The high-mobility group box 1 cytokine induces transporter-mediated release of glutamate from glial subcellular particles (gliosomes) prepared from in situ-matured astrocytes. Int Rev Neurobiol 82:73–93
Campos F, Sobrino T, Ramos-Cabrer P et al (2011) Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J Cereb Blood Flow Metab 31:1378–1386
Cheng S, Zhao Y, Li J, Chen X, Wang R, Zeng J (2014) Plasma levels of glutamate during stroke is associated with development of post-stroke depression. Psychoneuroendocrinology 47:126–135
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethics approval
The study was approved by the ethics committee of the Suzhou Ninth People’s Hospital.
Consent to participate
The patients gave written informed consent before entering the study.
Conflict of interest
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shan, W., Xu, L., Qiu, Z. et al. Increased high-mobility group box 1 levels are associated with depression after acute ischemic stroke. Neurol Sci 43, 3131–3137 (2022). https://doi.org/10.1007/s10072-021-05571-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05571-x